CN Patent

CN106361719A — 一种艾曲泊帕液体胶囊及其制备方法

Assigned to ZHEJIANG WANSHENG PHARMACEUTICAL Co Ltd · Expires 2017-02-01 · 9y expired

What this patent protects

本发明涉及一种艾曲泊帕液体胶囊及其制备方法。艾曲泊帕液体胶囊是将艾曲泊帕溶解于辅料中形成内容物，并将此内容物填充于硬胶囊壳中获得。本发明所述的辅料包括溶剂、表面活性剂、助表面活性剂、抗氧化剂、pH调节剂和适量的水分等。本发明所述的液体胶囊克服了艾曲泊帕溶解度低，难溶解和规格多，生产工艺复杂等缺点，给患者提供了更好的用药剂型选择。

USPTO Abstract

本发明涉及一种艾曲泊帕液体胶囊及其制备方法。艾曲泊帕液体胶囊是将艾曲泊帕溶解于辅料中形成内容物，并将此内容物填充于硬胶囊壳中获得。本发明所述的辅料包括溶剂、表面活性剂、助表面活性剂、抗氧化剂、pH调节剂和适量的水分等。本发明所述的液体胶囊克服了艾曲泊帕溶解度低，难溶解和规格多，生产工艺复杂等缺点，给患者提供了更好的用药剂型选择。

Drugs covered by this patent

Patent Metadata

Patent number
CN106361719A
Jurisdiction
CN
Classification
—
Expires
2017-02-01
Drug substance claim
No
Drug product claim
No
Assignee
ZHEJIANG WANSHENG PHARMACEUTICAL Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.